Polymorphism of gene UBE2E2 and the risk of developing diabetes type 2
https://doi.org/10.14341/DM2015346-50
Abstract
Recently, the ubiquitin–proteasome pathway has emerged as a crucial pathway for protein turnover, and it has also been identified as an important factor for insulin synthesis. This pathway plays a critical role inside β cells; therefore, it has naturally been linked with various insulin-related diseases, most notably type 2 diabetes mellitus (T2DM), but also other metabolic diseases and symptoms such as obesity and atherosclerotic plaques. The UBE2E2 gene encodes ubiquitin-conjugating enzyme E2 E2 (UBE2E2), which plays an important role in the synthesis and secretion of insulin. UBE2E2 is a protein expressed in the pancreas, liver, and adipose tissue, as well as in an insulin-secreting cell line . The results of some studies have indicated that single nucleotide polymorphisms on UBE2E2 (rs6780569, rs7612463, rs9812056) are associated with T2DM risk in Japanese, Korean and Chinese populations. Therefore, the UBE2E2 gene has started to draw interest from researchers because of its newly discovered relationships with various diseases.
Supporting agencies: National Natural Science Foundation of China (81172742, 81473053); Natural Science Foundation of Heilongjiang Province (ZD201220)
About the Authors
Elena Vladimirovna Kazakova
the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang
China
M.D.,employee of the Department of endocrinology, assistant Professor
Competing Interests: The authors have declared that no competing interests exist.
China
M.D.,employee of the Department of endocrinology, assistant Professor
Competing Interests: The authors have declared that no competing interests exist.
Yanhui Wu
the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang
China
M.D.,employee of the Department of endocrinology
Competing Interests: The authors have declared that no competing interests exist.
China
M.D.,employee of the Department of endocrinology
Competing Interests: The authors have declared that no competing interests exist.
Meijun Chen
the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang
Taiwan, Province of China
M.D., employee of the Department of endocrinology
Competing Interests: The authors have declared that no competing interests exist.
Taiwan, Province of China
M.D., employee of the Department of endocrinology
Competing Interests: The authors have declared that no competing interests exist.
Tongtong Wang
the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang
China
M.D., employee of the Department of endocrinology
Competing Interests: The authors have declared that no competing interests exist
China
M.D., employee of the Department of endocrinology
Competing Interests: The authors have declared that no competing interests exist
Lulu Sun
the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang
China
M.D., employee of the Department of endocrinology
Competing Interests: The authors have declared that no competing interests exist
China
M.D., employee of the Department of endocrinology
Competing Interests: The authors have declared that no competing interests exist
Hong Qiao
the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang
Taiwan, Province of China
M.D., Ph.D.
Competing Interests: The authors have declared that no competing interests exist
Taiwan, Province of China
M.D., Ph.D.
Competing Interests: The authors have declared that no competing interests exist
References
1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-787. doi: 10.1038/414782a
2. Wild S, Roglic G, Green A, et al. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes care. 2004;27(5):1047-1053. doi: 10.2337/diacare.27.5.104
3. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. The Lancet. 2005;365(9467):1333-1346. doi: 10.1016/S0140-6736(05)61032-X
4. Kobberling J, Tillil H. Empirical risk figures for first degree relatives of non-insulin dependent diabetics. The Genetics of Diabetes Mellitus. 1982; 201–209.
5. Rich SS. Mapping Genes in Diabetes: Genetic Epidemiological Perspective. Diabetes. 1990;39(11):1315-1319. doi: 10.2337/diab.39.11.1315
6. Meigs JB, Cupples LA, Wilson PW. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes. 2000;49(12):2201-2207. doi: 10.2337/diabetes.49.12.2201
7. Hemminki K, Försti A, Bermejo JL. Re: “Underlying genetic models of inheritance in established type 2 diabetes associations”. American Journal of Epidemiology. 2010;171(10):1153-1154. doi: 10.1093/aje/kwq058
8. Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Annals of the New York Academy of Sciences. 2010;1212:59-77. doi: 10.1111/j.1749-6632.2010.05838.x
9. Sanghera DK, Blackett PR. Type 2 Diabetes Genetics: Beyond GWAS. Journal of diabetes & metabolism. 2012;3(198):6948. doi: 10.4172/2155-6156.1000198
10. Hershko A., Ciechanover A. The ubiquitin system. Annual Review of Biochemistry. 1998;67:425-479. doi: 10.1146/annurev.biochem.67.1.425
11. Weissman AM. Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol. 2001;2(3):169-178. doi: 10.1038/35056563
12. Hicke L. Gettin’ down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends in Cell Biology. 1999;9(3):107-112. doi: 10.1016/S0962-8924(98)01491-3
13. Strous GJ, Govers R. The ubiquitin-proteasome system and endocytosis. Journal of Cell Science. 1999;112(10):1417-1423.
14. Koepp DM, Harper JW, Elledge SJ. How the cyclin became a cyclin. Cell. 1999;97(4):431-434. doi: 10.1016/S0092-8674(00)80753-9
15. Laney JD, Hochstrasser M. Substrate Targeting in the ubiquitin system. Cell. 1999;97(4):427-430. doi: 10.1016/S0092-8674(00)80752-7
16. López-Avalos MD, Duvivier-Kali VF, Xu G, et al. Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets. Diabetes. 2006;55(5):1223-1231. doi: 10.2337/db05-0450
17. Goldstein G, Scheid M, Hammerling U, et al. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proceedings of the National Academy of Sciences of the United States of America. 1975;72(1):11-15. doi: 10.1073/pnas.72.1.11
18. Kimura M, Hattori T, Matsuda Y, et al. cDNA cloning, characterization, and chromosome mapping of UBE2E2 encoding a human ubiquitin-conjugating E2 enzyme. Cytogenetic and Genome Research. 1997;78(2):107-111. doi: 10.1159/000134639
19. Dmitriev AA, Kashuba VI, Haraldson K, et al. Geneticandepigeneticanalysisofnon-smallcelllungcancerwithNotI-microarrays. Epigenetics. 2012;7(5):502-513. doi: 10.4161/epi.19801
20. Park KS. The search for genetic risk factors of type 2 diabetes mellitus. Diabetes & Metabolism Journal. 2011;35(1):12-22. doi: 10.4093/dmj.2011.35.1.12
21. Yamauchi T, Hara K, Maeda S, et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nature genetics. 2010;42(10):864-868. doi: 10.1038/ng.660
22. Iwata M, Maeda S, Kamura Y, et al. Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals.Diabetes care. 2012;35(8):1763-1770. doi: 10.2337/dc11-2006
23. Alharbi KK, Khan IA, Al-Sheikh YA, et al. Lack of association between UBE2E2 gene polymorphism (rs7612463) and type 2 diabetes mellitus in a Saudi population. Acta Biochimica Polomica. 2013;61(4):769-772.
24. Kazakova EV, Wu YH, Zhou ZY, et al. Association between UBE2E2 variant rs7612463 and type 2 diabetes mellitus in a Chinese Han Population. Acta Biochimica Polomica. 2015;62(2):241-245. doi: 10.18388/abp.2014_936
25. Kim JY, Cheong HS, Park B-L, et al. Putative association between UBE2E2 polymorphisms and the risk of gestational diabetes mellitus. Gynecological Endocrinology. 2013;29(10):904-908. doi: 10.3109/09513590.2013.813465
26. Rome S, Meugnier E, Vidal H. The ubiquitin-proteasome pathway is a new partner for the control of insulin signaling. Current Opinion in Clinical Nutrition & Metabolic Care. 2004;7(3):249-254. doi: 10.1097/00075197-200405000-00002
Supplementary files
Review
For citations:
Kazakova E.V., Wu Ya., Chen M., Wang T., Sun L., Qiao H. Polymorphism of gene UBE2E2 and the risk of developing diabetes type 2. Diabetes mellitus. 2015;18(3):46-50. https://doi.org/10.14341/DM2015346-50
Views:
907
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
